Home|Journals|Articles by Year Follow on Twitter

Directory for Medical Articles
 

Open Access

Original Research



Clinical audit of the high risk medications use in pediatric and neonatal intensive care units - Pre and post intervention

Anjali Goyal, Nazima Mirza, Rhythm, Monica Gupta, Bharat Gajjar.

Abstract
Background: Clinical audit is “a quality improvement process that seeks to improve patient care and outcomes through systematic review of care against explicit criterion and the implementation of change.” Prescribing of high-risk medications (HRMs) in pediatrics age group can pose a unique set of risk of medication errors, because of the need for individual dosage calculations.

Aim and Objective: The aim of the study was to evaluate the compliance to institutional guidelines while prescribing HRMs in the Neonatal Intensive Care Unit (NICU) and Pediatric Intensive Care Unit (PICU).

Materials and Methods: This was a record based retrospective observational study carried out in the NICU and PICU of Shree Krishna Hospital, Karamsad. The standard was evaluated against the four criteria mentioned in the institutional guidelines for the use of HRMs. These criteria were whether HRMs were (1) highlighted with red color in prescription, (2) prescribed in adequate dose, (3) verified by two nurses or doctors before administration, and (4) monitored after administration to the patient.

Results: A total of 36 and 37 case files were audited during the first and follow-up audit, respectively. The targets of 100% were achieved for criterion 2, 3 and 4 in the first audit as well as follow-up audit. The target of criterion 1 improved from 0% in the first audit to 46.66% in a follow-up audit.

Conclusion: Regular follow-up audits of HRM use are required to prevent medication errors and adverse drug reactions.

Key words: Clinical Audit; High-risk Medications; Medication errors



Similar Articles

Environmental stocks, CEO health risk and COVID-19.
Fernández-Méndez C, Pathan S
Research in international business and finance. 2022; 59(): 101509

Culturing and Expansion of "Clinical Grade" Neural Stem Cells from the Fetal Human Central Nervous System.
Gelati M, Profico DC, Ferrari D, Vescovi AL
Methods in molecular biology (Clifton, N.J.). 2022; 2389(): 57-66

Alternating in-source fragmentation with single-stage high-resolution mass spectrometry with high annotation confidence in non-targeted metabolomics.
Wasito H, Causon T, Hann S
Talanta. 2022; 236(): 122828

Leukoaraiosis is associated with clinical symptom severity, poor neurological function prognosis and stroke recurrence in mild intracerebral hemorrhage: a prospective multi-center cohort study.
Xu TQ, Lin WZ, Feng YL, Shen FX, Chen J, Wu WW, Zhu XD, Gu L, Fu Y
Neural regeneration research. 2022; 17(4): 819-823

Clinical potential of tension-lengthening strategies during nerve repair.
Bazarek S, Brown JM, Shah SB
Neural regeneration research. 2022; 17(4): 779-780


Full-text options


Latest Statistics about COVID-19
• pubstat.org


Add your Article(s) to Indexes
• citeindex.org






Covid-19 Trends and Statistics
ScopeMed.com
CiteIndex.org
CancerLine
FoodsLine
PhytoMedline
Follow ScopeMed on Twitter
Author Tools
eJPort Journal Hosting
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License (https://creativecommons.org/licenses/by-nc-sa/4.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
ScopeMed is a Database Service for Scientific Publications. Copyright © ScopeMed® Information Services.



ScopeMed Web Sites